Mittermayer H, Rotter M, Breitfellner G, Riezinger F, Thiel W, Binder L, Watschinger R
Institut für Medizinische Mikrobiologie und Hygiene, Krakenhauses der Elisabethinen, Linz.
Zentralbl Bakteriol. 1990 Apr;272(4):448-57. doi: 10.1016/s0934-8840(11)80046-0.
A total of 790 blood culture isolates was collected during 3 study periods in 1982/83, 1984/85 and 1987/88. Staphylococci were the most frequent bacteria in the first two periods (56.5% and 63%, respectively). During the last period, E. coli was the most frequent of all species (27%). Differences in the distribution of bacteria between the laboratories were considerable. In one laboratory in Vienna, coagulase-negative staphylococci dominated in all 3 study periods (32%, 33% and 47%). Susceptibility against gentamicin, tobramycin and netilmicin (MIC less than or equal to 4 mg/l), as well as against amikacin (MIC less than or equal to 8 mg/l) were determined by a microdilution method. The resistance rates against gentamicin (G) were 25%, 21% and 25%, against tobramycin (T) 27%, 19% and 25%, against netilmicin (N) 6%, 4% and 19%, and against amikacin (A), 5%, 2% and 19%. Most resistant strains were staphylococci (G 26%-41%, T 26%-46%, N 3%-31%, A 3%-36%), whereas gram-negative bacilli were more susceptible (G 12%-14%, T 7%-11%, N 7%-9%, A 1%-7.5%). The increase of resistance against netilmicin and amikacin in staphylococci was most striking. Nearly all those strain could be attributed to one laboratory in Vienna. Most of them were coagulase-negative staphylococci. In the first study period, the most frequent pattern was resistance against gentamicin and tobramycin, whereas in the last period resistance to all 4 aminoglycosides dominated. The study demonstrates considerable local differences in antibiotic resistance. Monitoring of antibiotic resistance in collaborative studies using standardized methods should be a valuable tool in planning strategies for controlling an epidemic spread of resistance.
在1982/83年、1984/85年和1987/88年的3个研究阶段共收集了790株血培养分离菌。在前两个阶段,葡萄球菌是最常见的细菌(分别占56.5%和63%)。在最后一个阶段,大肠杆菌是所有菌种中最常见的(占27%)。各实验室之间细菌分布的差异相当大。在维也纳的一个实验室,凝固酶阴性葡萄球菌在所有3个研究阶段均占主导地位(分别为32%、33%和47%)。采用微量稀释法测定了对庆大霉素、妥布霉素和奈替米星(MIC≤4mg/L)以及对阿米卡星(MIC≤8mg/L)的敏感性。对庆大霉素(G)的耐药率分别为25%、21%和25%,对妥布霉素(T)为27%、19%和25%,对奈替米星(N)为6%、4%和19%,对阿米卡星(A)为5%、2%和19%。大多数耐药菌株为葡萄球菌(G为26%-41%,T为26%-46%,N为3%-31%,A为3%-36%),而革兰氏阴性杆菌更易敏感(G为12%-14%,T为7%-11%,N为7%-9%,A为1%-7.5%)。葡萄球菌对奈替米星和阿米卡星耐药性的增加最为显著。几乎所有这些菌株都可归因于维也纳的一个实验室。其中大多数是凝固酶阴性葡萄球菌。在第一个研究阶段,最常见的模式是对庆大霉素和妥布霉素耐药,而在最后一个阶段,对所有4种氨基糖苷类药物耐药占主导。该研究表明抗生素耐药性存在相当大的局部差异。在合作研究中使用标准化方法监测抗生素耐药性应是规划控制耐药性流行传播策略的一个有价值的工具。